Search - tctmd.com

Displaying 501 - 520 of 891

Sort: Relevancy | Date

Presentation TCT 2017

Should Pre-Diabetes Affect Revascularization Decisions?

Presenter: David J. Maron, Alan C. Yeung, Clemens von Birgelen

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Presenter: David J. Maron, Alan C. Yeung, Michael E. Farkouh

November 01, 2017

Presentation TCT 2017

When to Use Cerebral Protection During TAVR

Presenter: Alfredo Trento, Alexandra J. Lansky

November 01, 2017

Presentation TCT 2017

Maintaining Knowledge and Skills: Continued Education

Presenter: Michael J. Rinaldi, David O. Williams, David A. Cox

November 01, 2017

Presentation TCT 2017

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

Presenter: Alfredo Trento, David J. Cohen

November 01, 2017

Presentation TCT 2017

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung

November 01, 2017

Presentation TCT 2017

Starting a Clinical Interventional Practice: Real-world Lessons

Presenter: Michael J. Rinaldi, David O. Williams, Ethan C Korngold

November 01, 2017

Presentation TCT 2017

Is There a Preferred Stent for the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Upendra Kaul

November 01, 2017

Presentation TCT 2017

Starting an Interventional Practice: An Academic Career

Presenter: Michael J. Rinaldi, David O. Williams, Mehdi H. Shishehbor

November 01, 2017

Presentation TCT 2017

When Should PCI Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Sripal Bangalore

November 01, 2017

Presentation TCT 2017

Challenges for the Young Interventionalist: Dual Citizenship and Training

Presenter: Michael J. Rinaldi, David O. Williams, Sahil A. Parikh

November 01, 2017

Presentation TCT 2017

When Should CABG Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Jack Boyd

November 01, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

Presentation TCT 2017

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

Presenter: Bernard Prendergast, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

The Most Important Clinical Trials of the Past Decade in Vascular Intervention

Presenter: Gary M. Ansel, Sahil A. Parikh, Andrew J. Klein

November 01, 2017

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

Kwan S. Lee

October 31, 2017

Presentation TCT 2017

Case #6: A Decapitated Left Main Coronary Stent

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Chee Yang Chin

October 31, 2017

Presentation TCT 2017

Outcomes and Clinical Implications From DECISION-CTO

Presenter: Barry D. Rutherford, Robert W. Yeh, Seung-Whan Lee

October 31, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Advertisement

Should Pre-Diabetes Affect Revascularization Decisions?

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

When to Use Cerebral Protection During TAVR

Maintaining Knowledge and Skills: Continued Education

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Starting a Clinical Interventional Practice: Real-world Lessons

Is There a Preferred Stent for the Diabetic Patient?

Starting an Interventional Practice: An Academic Career

When Should PCI Be Preferred in the Diabetic Patient?

Challenges for the Young Interventionalist: Dual Citizenship and Training

When Should CABG Be Preferred in the Diabetic Patient?

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

The Most Important Clinical Trials of the Past Decade in Vascular Intervention

Off Script: Focusing on the Future

Case #6: A Decapitated Left Main Coronary Stent

Outcomes and Clinical Implications From DECISION-CTO

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content